Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Incidence and Severity of Chemotherapyinduced Mucositis: A Cross-sectional Study

View through CrossRef
Introduction: Chemotherapy-induced Mucositis (CIM) is a debilitating complication in cancer treatment, affecting patient quality of life and often leading to treatment modifications. This study provides a comprehensive analysis of CIM’s incidence, severity, and associated risk factors in chemotherapy patients. Aim: To assess the incidence and severity of CIM and to determine the association between various risk factors of mucositis with the severity of CIM. Materials and Methods: A cross-sectional study was conducted with 164 adult cancer patients receiving chemotherapy in the Department of Oncology at a tertiary care hospital in Chennai, Tamil Nadu, India from May 2024 to October 2024. Data were gathered on demographics, cancer types, chemotherapy regimens, mucositis grades, and therapeutic interventions. CIM severity was graded as per the Common Terminology Criteria for Adverse Events (CTCAE). Chi-square test was used to analyse the association between the risk factors and the severity of CIM, using Statistical Packages of Social Sciences (SPSS) version 23.0. Results: The CIM developed in 99 patients (60.36%), with 70 (70.70%) experiencing Grade 2 and 3 severity. Mucositis was predominantly observed in the oral 29 (29.29%) and intestinal 25 (25.25%) regions. Middle-aged patients 41-60 years, those with co-morbid conditions, and patients on docetaxel-based regimens were at increased risk. L-glutamine supplementation was used as a preventive and treatment measure for CIM. Conclusion: The CIM is a frequent and severe side effect of chemotherapy, particularly among middle-aged patients and those with specific cancer regimens. Findings emphasise the need for preventive and management strategies to mitigate CIM’s impact, enhance patient outcomes, and reduce the burdens of cancer patients.
Title: Incidence and Severity of Chemotherapyinduced Mucositis: A Cross-sectional Study
Description:
Introduction: Chemotherapy-induced Mucositis (CIM) is a debilitating complication in cancer treatment, affecting patient quality of life and often leading to treatment modifications.
This study provides a comprehensive analysis of CIM’s incidence, severity, and associated risk factors in chemotherapy patients.
Aim: To assess the incidence and severity of CIM and to determine the association between various risk factors of mucositis with the severity of CIM.
Materials and Methods: A cross-sectional study was conducted with 164 adult cancer patients receiving chemotherapy in the Department of Oncology at a tertiary care hospital in Chennai, Tamil Nadu, India from May 2024 to October 2024.
Data were gathered on demographics, cancer types, chemotherapy regimens, mucositis grades, and therapeutic interventions.
CIM severity was graded as per the Common Terminology Criteria for Adverse Events (CTCAE).
Chi-square test was used to analyse the association between the risk factors and the severity of CIM, using Statistical Packages of Social Sciences (SPSS) version 23.
Results: The CIM developed in 99 patients (60.
36%), with 70 (70.
70%) experiencing Grade 2 and 3 severity.
Mucositis was predominantly observed in the oral 29 (29.
29%) and intestinal 25 (25.
25%) regions.
Middle-aged patients 41-60 years, those with co-morbid conditions, and patients on docetaxel-based regimens were at increased risk.
L-glutamine supplementation was used as a preventive and treatment measure for CIM.
Conclusion: The CIM is a frequent and severe side effect of chemotherapy, particularly among middle-aged patients and those with specific cancer regimens.
Findings emphasise the need for preventive and management strategies to mitigate CIM’s impact, enhance patient outcomes, and reduce the burdens of cancer patients.

Related Results

Evaluation of oral mucositis in pediatric cancer patients in Hiwa Hospital in Sulaymaniyah city, Kurdistan Region, Iraq
Evaluation of oral mucositis in pediatric cancer patients in Hiwa Hospital in Sulaymaniyah city, Kurdistan Region, Iraq
Background and objective: Oral mucositis is caused by the destruction of the oral mucosal epithelium and suppression of its growth secondary to antineoplastic treatment in the form...
Oral Mucositis, Incidence, Risk factors, Clinical Features, Scoring, Pathophysiology and Treatment: A Review of Literature
Oral Mucositis, Incidence, Risk factors, Clinical Features, Scoring, Pathophysiology and Treatment: A Review of Literature
Cancer is a broad group of different diseases involve the unregulated cell growth in which the cells divide uncontrollably forming the malignant tumors. The management are by chemo...
Topical application of hangeshashinto (TJ-14) in the management of chemotherapy-induced oral mucositis: A preliminary study.
Topical application of hangeshashinto (TJ-14) in the management of chemotherapy-induced oral mucositis: A preliminary study.
603 Background: Oral mucositis is a common toxicity associated with cytotoxic chemotherapy used for cancer treatment and results in severe discomfort and impairs patients' ability...
The Molecular Immunology of Mucositis: Implications for Evidence‐Based Research in Alternative and Complementary Palliative Treatments
The Molecular Immunology of Mucositis: Implications for Evidence‐Based Research in Alternative and Complementary Palliative Treatments
The terms ‘mucositis’ and ‘stomatitis’ are often used interchangeably. Mucositis, however, pertains to pharyngeal‐esophago‐gastrointestinal inflammation that manifests as red, bur...
Evaluation of Oral Mucositis and its Risk Factors in Patients with Head and Neck Cancer Undergoing Radiotherapy Treatment
Evaluation of Oral Mucositis and its Risk Factors in Patients with Head and Neck Cancer Undergoing Radiotherapy Treatment
Introduction: Oral mucositis is a painful and debilitating condition, often observed as an acute adverse effect of antineoplastic treatment. Patient-related risk factors, as age an...
An Impact of Coconut Oil Pulling on Oral Mucositis among Malignancy Patients
An Impact of Coconut Oil Pulling on Oral Mucositis among Malignancy Patients
Acute or chronic oral complications may develop around 400,000 patients each year during chemotherapy. Oral mucositis happens in around 40% of patients who get malignancy chemother...
THE EFFECT LOW LEVEL LASER THERAPY FOR MANAGEMENT OF RADIATION-INDUCEED MUCOSITIS
THE EFFECT LOW LEVEL LASER THERAPY FOR MANAGEMENT OF RADIATION-INDUCEED MUCOSITIS
Low-level laser therapy as a method for correcting the mucositis caused by ionizing radiation of the oral mucosa is used in clinical practice for various exposure parameters: radia...

Back to Top